Glenmark Pharmaceuticals

• 

  Glenmark Pharma Q1 Results: Profit Rises Exponentially To Rs 483 Crore; Revenue Jumps 23%

  Glenmark Pharmaceuticals reported a consolidated net profit of Rs 483 crore, compared with Rs 47 crore in the corresponding quarter last year.

• 

  Lupin, Zydus Lifesciences Among DRChoksey’s Top Picks As Pharma Sector Braces For Q3 — Check Full List

  Other notable picks include Alembic Pharma which is expected to benefit from specialty optionality and margin improvement.

• 

  Five Stocks To Buy: Glenmark, Paytm, IREDA, SBI And More

  Angel One and Religare Broking have shared target prices and stop losses for the above-mentioned stocks.

• 

  Glenmark Pharma Q2 Results: Profit Surges 72%, Revenue Zooms 76%

  Glenmark Pharmaceuticals Ltd.'s revenue also saw an uptick of 76.1% to Rs 6,047 crore compared to the previous year's Rs 3,434 crore.

• 

  Glenmark Pharma Interim Dividend — Last Day To Buy Shares To Qualify

  The board approved the interim dividend of Rs 2.5 per equity share on face value of Rs 1 per equity share for the financial year 2026.

• 

  Glenmark, Granules, Zydus Recall Products In US Over Manufacturing Issues: USFDA

  India has the highest number of USFDA-compliant pharmaceutical plants outside of the US.

• 

  Glenmark Pharmaceuticals To Trade Ex-Dividend This Week

  To be eligible for dividends, investors should take note of the record date, which determines shareholder eligibility.

• 

  Dividend, Bonus Issue, Stock Split This Week: Glenmark Pharma, Star Housing Finance, Paushak And More

  Here is a look at companies that declared dividends and have key dates coming up this week.

• 

  Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom

  The pharmaceutical sector has seen a flurry of new deals, partnerships, and drug launches this week, presenting potential significant growth opportunities in oncology, biosimilars, and diabetes care.

• 

  Stock Picks Today: Glenmark Pharma, Tata Consumer, ICICI Bank, Niva Bupa, Radico Khaitan On Brokerages' Radar

  Glenmark Pharma Ltd., Tata Consumer Products Ltd., Bharti Airtel Ltd., ICICI Bank Ltd., Radico Khaitan Ltd., are among the companies garnering brokerage commentary today.

• 

  Five Stocks To Buy Today: Glenmark Pharma, Bharti Airtel, Others—Check Target Price

  Five Stocks To Buy Today: The stock recommendations come with specific target price and stop loss price.

• 

  'Buy' Glenmark Pharma Shares Maintains Motilal Oswal Despite Weak Q1 Results — Check Target Price

  Motilal Oswal maintain 'Buy' rating on Glenmark Pharma and hikes target price sees strategic transformation to be underway

• 

  Glenmark Pharma Eyes 19-20% Ebitda Margin In FY26 Driven By Strong Performance Across Markets

  Glenmark Pharma is targeting revenue growth of 10-12% in FY26.

• 

  Glenmark Pharmaceuticals Q1 Results: Profit Plunges 86%

  The margin narrowed to 17.8% versus 18.1% in the year-ago period.

• 

  Glenmark Pharma Will Turn Cash Positive With AbbVie's Licensing Deal: S&P

  Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&P